Exelixis
EXEL
#1622
Rank
HK$76.62 B
Marketcap
HK$273.77
Share price
2.47%
Change (1 day)
54.22%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company